Blood lead concentration and thyroid function during pregnancy: Results from the yugoslavia prospective study of environmental lead exposure

Environmental Health Perspectives

Volumn 122, Issue 10, 2014, Pages 1134-1140

  Kahn, Linda G ^a   Liu, Xinhua ^a   Rajovic, Biljana ^b   Popovac, Dusan ^c   Oberfield, Sharon ^d   Graziano, Joseph H ^a   Factor Litvak, Pam ^a  

^a Department of Medicine   (United States)

^b Regional Hospital Kosovska Mitrovica   (Serbia)

^c UNIVERSITY OF PRI TINA   (Serbia)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE PROTOPORPHYRIN; LEAD; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; AUTOANTIBODY; POLLUTANT; THYROID MICROSOMAL ANTIBODIES;

ADULT; ALBANIAN (PEOPLE); ARTICLE; CHILD; CHILD GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PROSPECTIVE STUDY; QUESTIONNAIRE; SERBIAN (CITIZEN); SOCIAL STATUS; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROXINE BLOOD LEVEL; YUGOSLAVIA; ANALYSIS; BLOOD; EPIDEMIOLOGY; ODDS RATIO; POLLUTANT; SECOND TRIMESTER PREGNANCY; STATISTICS AND NUMERICAL DATA; TOXICITY;

ADULT; AUTOANTIBODIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LEAD; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; YUGOSLAVIA;

EID: 84907651961     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307669     Document Type: Article

References (72)

1. Ajmani SN, Aggarwal D, Bhatia P, Sharma M, Sarabhai V, Paul M. 2014. Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome. J Obstet Gynaecol India 64(2):105–110.
2. Bahn AK, Mills JL, Snyder PJ, Gann PH, Houten L, Bialik O, et al. 1980. Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med 302:31–33.
3. Bath S, Steer C, Golding J, Emmett P, Rayman M. 2013. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet 382(9889):331–337.
4. Belin R, Astor B, Powe N, Ladenson P. 2004. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the Third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 89(12):6077–6086.
5. Bellinger D. 2005. Teratogen update: lead and pregnancy. Birth Defects Res A Clin Mol Teratol 73:409–420.
6. Bellinger D. 2008. Very low lead exposures and children’s neurodevelopment. Curr Opin Pediatr 20(2):172–177.
7. Bellinger D, Leviton A, Rabinowitz M, Allred E, Needleman H, Schoenbaum S. 1991. Weight gain and maturity in fetuses exposed to low levels of lead. Environ Res 54(2):151–158.
8. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. 1987. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 316(17):1037–1043.
9. Blatt A, Nakamoto J, Kaufman H. 2012. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 97(3):777–784.
10. Bledsoe M, Pinkerton L, Silver S, Deddens J, Biagini R. 2011. Thyroxine and free thyroxine levels in workers occupationally exposed to inorganic lead. Environ Health Insights 5:55–61.
11. Boas M, Forman J, Juul A, Feldt-Rasmussen U, Skakkebaek N, Hilsted L, et al. 2009a. Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women. Eur J Endocrinol 161:903–910.
12. Boas M, Main KM, Feldt-Rasmussen U. 2009b. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes 16(5):385–391.
13. Bocchetta A, Loviselli A. 2006. Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health 2:23; doi:10.1186/1745-0179-2-23.
14. Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F. 1971. Enhanced susceptibility to iodine myxedema in patients with Hashimoto’s disease. J Clin Endocrinol Metab 32:515–521.
15. Brent G. 2010. Environmental exposures and autoimmune thyroid disease. Thyroid 20(7):755–761.
16. Brody D, Pirkle J, Kramer R, Flegal K, Matte T, Gunter E, et al. 1994. Blood lead levels in the US Population: phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA 272(4):277–283.
17. Burek CL, Talor MV. 2009. Environmental triggers of autoimmune thyroiditis. J Autoimmun 33(3–4):183–189.
18. Canfield R, Henderson C, Cory-Slechta D, Cox C, Jusko T, Lanphear B. 2003. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N Engl J Med 348(16):1517–1526.
19. Cantonwine D, Hu H, Sanchez B, Lamadrid-Figueroa H, Smith D, Ettinger A, et al. 2010. Critical windows of fetal lead exposure: adverse impacts on length of gestation and risk of premature delivery. J Occup Environ Med 52(11):1106–1111.
20. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Levenko KJ, Cunningham FG. 2005. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105(2):239–245.
21. Dietert RR, Piepenbrink MS. 2006. Lead and immune function. Crit Rev Toxicol 36:359–385.
22. Dietrich K, Krafft K, Bornschein R, Hammond P, Berger O, Succop P, et al. 1987. Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics 80(5):721–730.
23. Dooyema C, Neri A, Lo Y-C, Durant J, Dargan P, Swarthout T, et al. 2012. Outbreak of fatal childhood lead poisoning related to artisanal gold mining in northwestern Nigeria, 2010. Environ Health Perspect 120:601–607; doi:10.1289/ehp.1103965.
24. Dundar B, Oktem F, Arslan M, Delibas N, Baykal B, Arslan C, et al. 2006. The effect of long-term low-dose lead exposure on thyroid function in adolescents. Environ Res 101:140–145.
25. Duntas LH. 2010. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 95(12):5180–5188.
26. Effraimidis G, Tijssen J, Wiersinga W. 2009. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab 94(4):1324–1328.
27. El-Fawal HA, Waterman SJ, Feo AD, Shamy MY. 1999. Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms. Environ Health Perspect 107(suppl 5):767–775.
28. Ernhart C, Morrow-Tlucak M, Wolf A, Super D, Drotar D. 1989. Low level lead exposure in the prenatal and early preschool periods: intelligence prior to school entry. Neurotoxicol Teratol 11(2):161–170.
29. de Escobar GM, Obregon M, Rey Fd. 2004. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 18(2):225–248.
30. Factor-Litvak P, Graziano J, Kline J, Popovac D, Mehmeti A, Ahmedi G, et al. 1991. A prospective study of birthweight and length of gestation in a population surrounding a lead smelter in Kosovo, Yugoslavia. Int J Epidemiol 20:722–728.
31. Factor-Litvak P, Wasserman G, Kline J, Graziano J. 1999. The Yugoslavia Prospective Study of Environmental Lead Exposure. Environ Health Perspect 107:9–15.
32. Glinoer D. 2000. Thyroid disease during pregnancy. In: Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Test (Braverman L, Utiger R, eds). Philadelphia, PA:Lippincott Williams & Wilkins, 1013–1027.
33. Goebel C, Flohe SB, Kirchhoff K, Herder C, Kolb H. 2000. Orally administered lead chloride induces bias of mucosal immunity. Cytokine 12(9):1414–1418.
34. Gomaa A, Hu H, Bellinger D, Schwartz J, Tsaih S, Gonzalez-Cossio T, et al. 2002. Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics 110(1 part 1):110–118.
35. Gonzalez-Cossio T, Peterson K, Sanin L, Fishbein E, Palazuelos E, Aro A, et al. 1997. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics 100(5):856–862.
36. Graziano J, Popovac D, Factor-Litvak P, Shrout P, Kline J, Murphy M, et al. 1990. Determinants of elevated blood lead during pregnancy in a population surrounding a lead smelter in Kosovo, Yugoslavia. Environ Health Perspect 89:95–100.
37. Haddow J, Palomaki G, Allan W, Williams J, Knight G, Gagnon J, et al. 1999. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341(8):549–555.
38. Hartoft-Nielsen M, Boas M, Bliddal S, Rasmussen ÅK, Main K, Feldt-Rasmussen U. 2011. Do thyroid disrupting chemicals influence foetal development during pregnancy? J Thyroid Res; doi:10.4061/2011/342189.
39. Heo Y, Lee WT, Lawrence DA. 1998. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol Sci 43(2):172–185.
40. Hernandez-Avila M, Peterson K, Gonzalez-Cossio T, Sanin L, Aro A, Schnaas L, et al. 2002. Effect of maternal bone lead on length and head circumference of newborns and 1-month-old infants. Arch Environ Health 57(5):482–488.
41. Hertz-Picciotto I, Schramm M, Watt-Morse M, Chantala K, Anderson J, Osterloh J. 2000. Patterns and determinants of blood lead during pregnancy. Am J Epidemiol 152(9):829–837.
42. Hudson CA, Cao L, Kasten-Jolly J, Kirkwood JN, Lawrence DA. 2003. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health 66(10):895–918.
43. Lahner E, Centanni M, Agnello G, Gargano L, Vannella L, Iannoni C, et al. 2008. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 121(2):136–141.
44. Lamb MR, Janevic T, Liu X, Cooper T, Kline J, Factor-Litvak P. 2008. Environmental lead exposure, maternal thyroid function, and childhood growth. Environ Res 106(2):195–202.
45. Langer P, Kocan A, Tajtakova M, Koska J, Radikova Z, Ksinantova L, et al. 2008. Increased thyroid volume, prevalence of thyroid antibodies and impaired fasting glucose in young adults from organochlorine cocktail polluted area: outcome of transgenerational transmission? Chemosphere 73(7):1145–1150.
46. Langer P, Kocan A, Tajtakova M, Petrik J, Chovancova J, Drobna B, et al. 2007. Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia. Chemosphere 67(9):S379–S385.
47. Lanphear B, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger D, et al. 2005. Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect 113:894–899; doi:10.1289/ehp.7688.
48. Lazarus J, Bestwick J, Channon S, Paradice R, Maina A, Rees R, et al. 2012. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 366(6):493–501.
49. Man E, Serunian S. 1976. Thyroid function in human pregnancy. IX. Development or retardation of 7-year-old progeny of hypothyroxinemic women. Am J Obstet Gynecol 125(7):949.
50. Mannisto T, Surcel H, Bloigu A, Ruokonen A, Hartikainen A, Jarvelin M, et al. 2007. The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks. Clin Chem 53(11):1986–1987.
51. Mbah A, Ejim E, Onodugo O, Ezugwu F, Eze M, Nkwo P, et al. 2011. Two logistic models for the prediction of hypothyroidism in pregnancy. BMC Res Notes 4:205–214.
52. + T cell subsets. Toxicol Appl Pharmacol 111(1):13–23.
53. McMichael A, Baghurst P, Wigg N, Vimpani G, Robertson E, Roberts R. 1988. Port Pirie Cohort Study: environmental exposure to lead and children’s abilities at the age of four years. N Engl J Med 319(8):468–475.
54. Needleman H, Landrigan P. 1991. The health effects of low level exposure to lead. Annu Rev Public Health 2:277–298.
55. Opler MGA, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C, et al. 2004. Prenatal lead exposure, deltaaminolevulinic acid, and schizophrenia. Environ Health Perspect 112:548–552; doi:10.1289/ehp.6777.
56. Opler MGA, Buka SL, Groeger J, McKeague I, Wei C, Factor-Litvak P, et al. 2008. Prenatal exposure to lead, δ-amniolevulinic acid, and schizophrenia: further evidence. Environ Health Perspect 116:1586–1590; doi:10.1289/ehp.10464.
57. Pearce EN, Braverman LE. 2009. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab 23(6):801–813.
58. Pop V, deVries E, vanBaar A, Waelkens J, deRooy H, Horsten M, et al. 1995. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 80(12):3561–3566.
59. Popovac D, Graziano J, Seaman C, Kaul B, Colakovic B, Popovac R, et al. 1982. Elevated blood lead in a population near a lead smelter in Kosovo, Yugoslavia. Arch Environ Health 37:19–23.
60. Sandstead H, Stant E, Brill A, Arias L, Terry R. 1969. Lead intoxication and the thyroid. Arch Intern Med 123:632–635.
61. Schnaas L, Rothenberg SJ, Flores F, Martinez S, Hernandez C, Osorio E, et al. 2006. Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect 114:791–797; doi:10.1289/ehp.8552.
62. Slingerland D. 1955. The influence of various factors on the uptake of iodine by the thyroid. J Clin Endocrinol Metab 15:131–141.
63. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21(10):1081–1125.
64. Stagnaro-Green A, Pearce EN. 2013. Iodine and pregnancy: a call to action. Lancet 382(9889):292–293.
65. Tajiri J, Higashi K, Morita M, Umeda T, Sato T. 1986. Studies of hypothyroidism in patients with high iodine intake. J Clin Endocrinol Metab 63:412–417.
66. Tuppurainen M, Wagar G, Kurppa K, Sakari W, Wambugu A, Froseth B, et al. 1988. Thyroid function as assessed by routine laboratory tests of workers with long-term lead exposure. Scand J Work Environ Health 14:175–180.
67. van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M, et al. 2011. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 17(5):605–619.
68. Wasserman G, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, et al. 2000. The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol 22(6):811–818.
69. Wasserman G, Staghezza-Jaramillo B, Shrout P, Popovac D, Graziano J. 1998. The effect of lead exposure on behavior problems in preschool children. Am J Public Health 88:481–486.
70. Waterman SJ, El-Fawal HA, Snyder CA. 1994. Lead alters the immunogenicity of two neural proteins: a potential mechanism for the progression of lead-induced neurotoxicity. Environ Health Perspect 102:1052–1056.
71. Zheng W, Lu Y, Lu G, Zhao Q, Cheung O, Blaner W. 2001. Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure. Toxicol Sci 61(1):107–114.
72. Zheng W, Shen H, Blaner W, Zhao Q, Ren X, Graziano J. 1996. Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: the role of the choroid plexus. Toxicol Appl Pharmacol 139(2):445–450.